SURMODICS INC — Director's Dealing 2014

Nov 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2014-11-19

Reporting Person: Arens Timothy J. (VP-Corporate Dev. and Strategy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-19	Common Stock	M	10330	$9.25	Acquired	16722	Direct
2014-11-19	Common Stock	S	10330	$21.023	Disposed	6392	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-19	Employee Stock Option (right to buy)	$9.25	M	10330	Disposed	2017-11-30	Common Stock (10330)	Direct

Footnotes

F1: Reflects the weighted average price of 10,330 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 19, 2014 with sale prices ranging from $20.90 to $21.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2010 grant date.